Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function

Area of Science:

• Transplantation immunology
• Organ transplantation research
• Complement system in allograft rejection

Background:

• Lung dysfunction post-transplantation remains a significant clinical challenge.
• Soluble complement receptor 1 (sCR1) effectively inhibits complement activation.
• This study investigates sCR1's impact on complement activation and reperfusion injury in lung allografts.

Purpose of the Study:

• To evaluate the efficacy of sCR1 in mitigating complement activation and reperfusion injury in a porcine lung allograft model.
• To assess the functional outcomes of lung allografts treated with sCR1 compared to controls.

Main Methods:

• A randomized, blinded study involving 13 pigs undergoing left lung transplantation.
• Donor lungs were flushed and stored for 30 hours.
• Treatment group (n=6) received sCR1 (15 mg/kg) 1 hour pre-reperfusion; control group (n=7) received saline.
• Pulmonary function was assessed at 1 hour and 3 days post-reperfusion.

Main Results:

• sCR1 achieved 93% complement inhibition, returning to baseline by day 3.
• Improved alveolar ventilation (P=0.01) and a trend towards higher oxygen partial pressure at 1 hour in the sCR1 group.
• Reduced pulmonary edema (lower wet/dry weight, P<0.05) and lower mixed venous saturation in controls (P=0.02 at 1 hr, P=0.001 at 3 days).

Conclusions:

• sCR1 administration demonstrates a beneficial effect on lung allograft function.
• It improves ventilation and reduces pulmonary edema, key indicators of post-transplant lung health.
• sCR1 holds potential for improving oxygenation and outcomes in lung transplantation.